Viking Therapeutics (VKTX) Posts Q2 Loss of $1.07/Share

Go back to Viking Therapeutics (VKTX) Posts Q2 Loss of $1.07/Share
ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) Delayed: 29.95 --0 (-0%)
Previous Close $29.95    52 Week High $5.17 
Open $29.95    52 Week Low $0.94 
Day High $29.95    P/E N/A 
Day Low $29.95    EPS $0.00 
Volume 1,045